AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $416 | -99.2% | 14 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $51,712 | +2485.6% | 1,911 | +1702.8% | 0.01% | – |
| Q3 2022 | $2,000 | +100.0% | 106 | +324.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 25 | -45.7% | 0.00% | – |
| Q1 2022 | $2,000 | -84.6% | 46 | -86.9% | 0.00% | -100.0% |
| Q2 2021 | $13,000 | -13.3% | 352 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $15,000 | -81.9% | 349 | -80.7% | 0.00% | -94.4% |
| Q4 2020 | $83,000 | -79.6% | 1,804 | -85.3% | 0.02% | -30.8% |
| Q3 2020 | $407,000 | +8.0% | 12,262 | -4.3% | 0.03% | +4.0% |
| Q2 2020 | $377,000 | -4.3% | 12,814 | -12.5% | 0.02% | -19.4% |
| Q1 2020 | $394,000 | +462.9% | 14,649 | +602.3% | 0.03% | +675.0% |
| Q4 2019 | $70,000 | – | 2,086 | +17283.3% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 12 | -66.7% | 0.00% | – |
| Q2 2019 | $2,000 | -99.7% | 36 | -99.8% | 0.00% | -100.0% |
| Q4 2018 | $781,000 | -35.2% | 17,438 | -1.0% | 0.07% | -22.2% |
| Q3 2018 | $1,206,000 | – | 17,616 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |